{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:01:47Z","timestamp":1784854907614,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) remains a major global health burden and a leading cause of cancer-related mortality. Advanced disease is characterized by a profoundly immunosuppressive tumor microenvironment (TME) and limited durable responses to therapy. However, the upstream genetic determinants that drive tumor-associated macrophage (TAM) dysfunction in HCC remain poorly defined. Using an integrative genetic and multi-omics framework, we investigated complement receptor 1 (CR1) as a candidate regulator of this immunosuppressive niche.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We combined Mendelian randomization (MR) and metabolite mediation analyses with bulk, single-cell, and spatial transcriptomics to define the role of CR1 in HCC. Public datasets included the TCGA-HCC cohort, a single-cell RNA-sequencing dataset comprising 53,474 high-quality cells from 21 samples, and two spatially profiled HCC sections. Clinical validation was performed in 30 paired HCC and adjacent liver tissues. Functional assays were conducted in THP-1-derived macrophages using CR1 gain- and loss-of-function approaches, phagocytosis assays, and macrophage-CD8\n                      <jats:sup>+<\/jats:sup>\n                      T-cell co-culture experiments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MR analyses implicated CR1 in HCC susceptibility at both the protein and transcript levels. pQTL analysis linked genetically predicted circulating CR1 levels to HCC risk (IVW OR\u2009=\u20091.403,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017), and mediation analysis identified specific metabolites as candidate intermediates. Integrative multi-omics analyses showed that CR1 was preferentially enriched in TAMs, spatially co-localized with the M2 marker CD206, and associated with reduced CD8\n                      <jats:sup>+<\/jats:sup>\n                      T-cell infiltration, enhanced T-cell exhaustion signatures, advanced clinicopathological features, and poorer survival. In 30 paired clinical samples, CR1-high tumors exhibited increased M2-like macrophage accumulation and reduced CD8\n                      <jats:sup>+<\/jats:sup>\n                      T-cell infiltration. Functionally, CR1 overexpression drove macrophages toward an M2-like phenotype, enhanced phagocytic activity, increased PD-L1 expression, and suppressed CD8\n                      <jats:sup>+<\/jats:sup>\n                      T-cell proliferation as well as IFN-gamma and granzyme B production, whereas CR1 knockdown produced the opposite phenotype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our study provides the first integrated genetic, spatial, and functional evidence that CR1\n                      <jats:sup>+<\/jats:sup>\n                      TAMs constitute a clinically relevant immunoregulatory axis in HCC. These findings extend current understanding of complement-associated immunosuppression beyond canonical complement cascade activity and support CR1 as a candidate biomarker and therapeutic target for macrophage reprogramming, with potential translational relevance for combination strategies involving immune checkpoint blockade.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08301-z","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:55:05Z","timestamp":1779692105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CR1(+) tumor-associated macrophages orchestrate an immunosuppressive niche in hepatocellular carcinoma: a genetic and multi-omics dissection"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhengjian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuda","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1533-5694","authenticated-orcid":false,"given":"Fangfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"12","key":"8301_CR1","doi-asserted-by":"publisher","first-page":"101571","DOI":"10.1016\/j.jhepr.2025.101571","volume":"7","author":"E Mauro","year":"2025","unstructured":"Mauro E, de Castro T, Zeitlhoefler M, Sung MW, Villanueva A, Mazzaferro V, et al. Hepatocellular carcinoma: epidemiology, diagnosis and treatment. JHEP Rep. 2025;7(12):101571. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101571.","journal-title":"JHEP Rep"},{"key":"8301_CR2","doi-asserted-by":"publisher","unstructured":"Hwang SY, Danpanichkul P, Agopian V, Mehta N, Parikh ND, Abou-Alfa GK, et al. Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment. Clin Mol Hepatol. 2025;31(Suppl):S228\u2013s254. https:\/\/doi.org\/10.3350\/cmh.2024.0824.","DOI":"10.3350\/cmh.2024.0824"},{"issue":"10504","key":"8301_CR3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","volume":"406","author":"SL Chan","year":"2025","unstructured":"Chan SL, Sun HC, Xu Y, Zeng H, El-Serag HB, Lee JM, Schwartz ME, Finn RS, Seong J, Wang XW, et al. The Lancet commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment. Lancet. 2025;406(10504):731\u201378. https:\/\/doi.org\/10.1016\/S0140-6736(25)01042-6.","journal-title":"Lancet"},{"issue":"10352","key":"8301_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","volume":"400","author":"KB Tran","year":"2022","unstructured":"Tran KB, Lang JJ, Compton K, Xu R, Acheson AR, Henrikson HJ, et al. The global burden of cancer attributable to risk factors, 2010\u201319: a systematic analysis for the global burden of disease study 2019. Lancet. 2022;400(10352):563\u201391. https:\/\/doi.org\/10.1016\/S0140-6736(22)01438-6.","journal-title":"Lancet"},{"issue":"3","key":"8301_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, et al. Cancer incidence, mortality, Years of Life lost, Years lived with Disability, and Disability-adjusted Life Years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8(3):420\u201344. https:\/\/doi.org\/10.1001\/jamaoncol.2021.6987.","journal-title":"JAMA Oncol"},{"key":"8301_CR6","doi-asserted-by":"publisher","unstructured":"Patel KR, Menon H, Patel RR, Huang EP, Verma V, Escorcia FE. Locoregional therapies for hepatocellular carcinoma: a systematic review and meta-analysis. JAMA Netw Open. 2024;7(11):e2447995. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.47995.","DOI":"10.1001\/jamanetworkopen.2024.47995"},{"issue":"10","key":"8301_CR7","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1097\/MEG.0000000000000688","volume":"28","author":"E Sheta","year":"2016","unstructured":"Sheta E, El-Kalla F, El-Gharib M, Kobtan A, Elhendawy M, Abd-Elsalam S, et al. Comparison of single-session transarterial chemoembolization combined with microwave ablation or radiofrequency ablation in the treatment of hepatocellular carcinoma: a randomized-controlled study. Eur J Gastroenterol Hepatol. 2016;28(10):1198\u2013203. https:\/\/doi.org\/10.1097\/MEG.0000000000000688.","journal-title":"Eur. J. Gastroenterol. Hepatol"},{"issue":"8","key":"8301_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","volume":"18","author":"B Sangro","year":"2021","unstructured":"Sangro B, Sarobe P, Herv\u00e1s-Stubbs S, Melero I. Advances in immunotherapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18(8):525\u201343. https:\/\/doi.org\/10.1038\/s41575-021-00438-0.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"18","key":"8301_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/cancers17183034","volume":"17","author":"F Tounkara","year":"2025","unstructured":"Tounkara F, Sherpally D, Mumtaz K, Makary MS, Palm RF, Manne A. Immune checkpoint inhibitor use in advanced hepatocellular carcinoma: a real-world analysis of efficacy and toxicity. Cancers (Basel). 2025;17(18):17. https:\/\/doi.org\/10.3390\/cancers17183034.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"8301_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40164-024-00539-x","volume":"13","author":"Y Yin","year":"2024","unstructured":"Yin Y, Feng W, Chen J, Chen X, Wang G, Wang S, et al. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside. Exp Hematol Oncol. 2024;13(1):72. https:\/\/doi.org\/10.1186\/s40164-024-00539-x.","journal-title":"Exp Hematol Oncol"},{"issue":"10","key":"8301_CR11","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/s41423-025-01308-4","volume":"22","author":"D Seyhan","year":"2025","unstructured":"Seyhan D, Allaire M, Fu Y, Conti F, Wang XW, Gao B, et al. Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy. Cell Mol Immunol. 2025;22(10):1132\u201358. https:\/\/doi.org\/10.1038\/s41423-025-01308-4.","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"8301_CR12","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1007\/s11033-020-05564-7","volume":"47","author":"M Elhendawy","year":"2020","unstructured":"Elhendawy M, Abdul-Baki EA, Abd-Elsalam S, Hagras MM, Zidan AA, Abdel-Naby AY, et al. Correction to: MicroRNA signature in hepatocellular carcinoma patients: identification of potential markers. Mol Biol Rep. 2020;47(7):4955. https:\/\/doi.org\/10.1007\/s11033-020-05564-7.","journal-title":"Mol Biol Rep"},{"key":"8301_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.molliq.2017.03.112","volume":"234","author":"I Ali","year":"2017","unstructured":"Ali I, Lone MN, Alothman ZA, Alwarthan A. Insights into the pharmacology of new heterocycles embedded with oxopyrrolidine rings: DNA binding, molecular docking, and anticancer studies. J Mol Liq. 2017;234:391\u2013402. https:\/\/doi.org\/10.1016\/j.molliq.2017.03.112.","journal-title":"J Mol Liq"},{"issue":"5","key":"8301_CR14","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.jhep.2025.10.026","volume":"84","author":"S Zhang","year":"2026","unstructured":"Zhang S, Xu H, Li M, Yuan G, Nie J, Zhang Q, et al. An etiology-stratified single-cell atlas identifies FABP4 as a prognostic marker for MASLD-related HCC. J Educ Chang Hepatol. 2026;84(5):920\u201332. https:\/\/doi.org\/10.1016\/j.jhep.2025.10.026.","journal-title":"J Educ Chang Hepatol"},{"issue":"10","key":"8301_CR15","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/bmc.2953","volume":"27","author":"I Ali","year":"2013","unstructured":"Ali I, Haque A, Wani WA, Saleem K, Al Za\u2019abi M. Analyses of anticancer drugs by capillary electrophoresis: a review. Biomed Chromatogr: BMC. 2013;27(10):1296\u2013311. https:\/\/doi.org\/10.1002\/bmc.2953.","journal-title":"Biomed Chromatogr: BMC"},{"issue":"20","key":"8301_CR16","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2174\/0929867323666160405111152","volume":"23","author":"I Ali","year":"2016","unstructured":"Ali I, Lone MN, Suhail M, Mukhtar SD, Asnin L. Advances in Nanocarriers for anticancer drugs delivery. CMC. 2016;23(20):2159\u201387. https:\/\/doi.org\/10.2174\/0929867323666160405111152.","journal-title":"CMC"},{"issue":"1","key":"8301_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/157340613804488297","volume":"9","author":"I Ali","year":"2013","unstructured":"Ali I, Wani WA, Saleem K, Wesselinova D. Syntheses, DNA binding and anticancer profiles of L-glutamic acid ligand and its copper(II) and ruthenium(III) complexes. Med Chem. 2013;9(1):11\u201321. https:\/\/doi.org\/10.2174\/157340613804488297.","journal-title":"Med Chem"},{"issue":"8","key":"8301_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/ijms24087463","volume":"24","author":"B Foglia","year":"2023","unstructured":"Foglia B, Beltr\u00e0 M, Sutti S, Cannito S. Metabolic reprogramming of HCC: a New microenvironment for immune responses. IJMS. 2023;24(8):24. https:\/\/doi.org\/10.3390\/ijms24087463.","journal-title":"IJMS"},{"key":"8301_CR19","doi-asserted-by":"publisher","first-page":"129148","DOI":"10.1016\/j.molstruc.2020.129148","volume":"1225","author":"MA Almehmadi","year":"2021","unstructured":"Almehmadi MA, Aljuhani A, Alraqa SY, Ali I, Rezki N, Aouad MR, et al. Design, synthesis, DNA binding, modeling, anticancer studies and DFT calculations of Schiff bases tethering benzothiazole-1,2,3-triazole conjugates. J Mol Struct. 2021;1225:129148. https:\/\/doi.org\/10.1016\/j.molstruc.2020.129148.","journal-title":"J Mol Struct"},{"issue":"4","key":"8301_CR20","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1159\/000542578","volume":"14","author":"Y Lin","year":"2024","unstructured":"Lin Y, Ruze R, Zhang R, Tuergan T, Wang M, Tulahong A, et al. Immunometabolic targets in CD8 + T cells within the tumor microenvironment of hepatocellular carcinoma. Liver Cancer. 2024;14(4):474\u201396. https:\/\/doi.org\/10.1159\/000542578.","journal-title":"Liver Cancer"},{"issue":"2","key":"8301_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/08820139.2017.1407787","volume":"47","author":"N Elwan","year":"2018","unstructured":"Elwan N, Salem ML, Kobtan A, El-Kalla F, Mansour L, Yousef M, et al. High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients. Immunol Invest. 2018;47(2):169\u201380. https:\/\/doi.org\/10.1080\/08820139.2017.1407787.","journal-title":"Immunol Invest"},{"issue":"23","key":"8301_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/ijms252313167","volume":"25","author":"ME Bannister","year":"2024","unstructured":"Bannister ME, Chatterjee DA, Shetty S, Patten DA. The role of macrophages in hepatocellular carcinoma and their therapeutic potential. IJMS. 2024;25(23):25. https:\/\/doi.org\/10.3390\/ijms252313167.","journal-title":"IJMS"},{"key":"8301_CR23","doi-asserted-by":"publisher","first-page":"101234","DOI":"10.1016\/j.neo.2025.101234","volume":"69","author":"T Nosaka","year":"2025","unstructured":"Nosaka T, Ohtani M, Yamashita J, Murata Y, Akazawa Y, Tanaka T, et al. PD-L1(+) tumor-associated macrophages induce CD8(+) T cell exhaustion in hepatocellular carcinoma. Neoplasia. 2025;69:101234. https:\/\/doi.org\/10.1016\/j.neo.2025.101234.","journal-title":"Neoplasia"},{"key":"8301_CR24","doi-asserted-by":"publisher","first-page":"106375","DOI":"10.1016\/j.intimp.2020.106375","volume":"82","author":"MT Abdel Ghafar","year":"2020","unstructured":"Abdel Ghafar MT, Morad MA, El-Zamarany EA, Ziada D, Soliman H, Abd-Elsalam S, et al. Autologous dendritic cells pulsed with lysate from an allogeneic hepatic cancer cell line as a treatment for patients with advanced hepatocellular carcinoma: a pilot study. Int Immunopharmacol. 2020;82:106375. https:\/\/doi.org\/10.1016\/j.intimp.2020.106375.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"8301_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","volume":"10","author":"J Xu","year":"2025","unstructured":"Xu J, Ding L, Mei J, Hu Y, Kong X, Dai S, et al. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Sig Transduct Target Ther. 2025;10(1):268. https:\/\/doi.org\/10.1038\/s41392-025-02325-5.","journal-title":"Sig Transduct Target Ther"},{"issue":"2","key":"8301_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.immuni.2021.01.011","volume":"54","author":"RW Sayaman","year":"2021","unstructured":"Sayaman RW, Saad M, Thorsson V, Hu D, Hendrickx W, Roelands J, et al. Germline genetic contribution to the immune landscape of cancer. Immunity. 2021;54(2):367\u201386.e8. https:\/\/doi.org\/10.1016\/j.immuni.2021.01.011.","journal-title":"Immunity"},{"issue":"1","key":"8301_CR27","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1038\/s41467-023-38271-5","volume":"14","author":"M Pagadala","year":"2023","unstructured":"Pagadala M, Sears TJ, Wu VH, P\u00e9rez-Guijarro E, Kim H, Castro A, et al. Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response. Nat Commun. 2023;14(1):2744. https:\/\/doi.org\/10.1038\/s41467-023-38271-5.","journal-title":"Nat Commun"},{"issue":"1","key":"8301_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/jitc-2024-008876","volume":"13","author":"A Cesano","year":"2025","unstructured":"Cesano A, Augustin R, Barrea L, Bedognetti D, Bruno TC, Carturan A, et al. Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a society for immunotherapy of cancer (SITC) review. J Immunother Cancer. 2025;13(1):13. https:\/\/doi.org\/10.1136\/jitc-2024-008876.","journal-title":"J Immunother Cancer"},{"key":"8301_CR29","doi-asserted-by":"publisher","first-page":"115332","DOI":"10.1016\/j.ejca.2025.115332","volume":"220","author":"AF Karimova","year":"2025","unstructured":"Karimova AF, Khalitova AR, Suezov R, Markov N, Mukhamedshina Y, Rizvanov AA, et al. Immunometabolism of tumor-associated macrophages: a therapeutic perspective. Eur J Criminol Cancer. 2025;220:115332. https:\/\/doi.org\/10.1016\/j.ejca.2025.115332.","journal-title":"Eur J Criminol Cancer"},{"key":"8301_CR30","doi-asserted-by":"publisher","unstructured":"Pal P, Wahi P, Sahu A, Lal G. Pro- and anti-inflammatory role of complement in cancer. Eur J Immunol. 2025;55(6):e51767. https:\/\/doi.org\/10.1002\/eji.202451767.","DOI":"10.1002\/eji.202451767"},{"key":"8301_CR31","doi-asserted-by":"publisher","unstructured":"Merle NS, Roumenina LT. The complement system as a target in cancer immunotherapy. Eur J Immunol. 2024;54:e2350820. https:\/\/doi.org\/10.1002\/eji.202350820.","DOI":"10.1002\/eji.202350820"},{"key":"8301_CR32","doi-asserted-by":"publisher","first-page":"101931","DOI":"10.1016\/j.smim.2025.101931","volume":"77","author":"R Saxena","year":"2025","unstructured":"Saxena R, Gottlin EB, Campa MJ, He YW, Patz EF Jr. Complement regulators as novel targets for anti-cancer therapy: a comprehensive review. Semin Immunol. 2025;77:101931. https:\/\/doi.org\/10.1016\/j.smim.2025.101931.","journal-title":"Semin Immunol"},{"key":"8301_CR33","doi-asserted-by":"publisher","first-page":"1519465","DOI":"10.3389\/fimmu.2025.1519465","volume":"16","author":"de Freitas Oliveira-Tore C","year":"2025","unstructured":"de Freitas Oliveira-Tore C, de Moraes Ag, Pl\u00e1cido, Signorini N, Fontana PD, da Piedade Batista Godoy T, et al. Non-canonical extracellular complement pathways and the complosome paradigm in cancer: a scoping review. Front. Immunol. 2025;16:1519465. https:\/\/doi.org\/10.3389\/fimmu.2025.1519465.","journal-title":"Front. Immunol"},{"issue":"1","key":"8301_CR34","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41698-024-00752-1","volume":"8","author":"J Ye","year":"2024","unstructured":"Ye J, Lin Y, Liao Z, Gao X, Lu C, Lu L, et al. Single cell-spatial transcriptomics and bulk multi-omics analysis of heterogeneity and ecosystems in hepatocellular carcinoma. npj Precis. Onc. 2024;8(1):262. https:\/\/doi.org\/10.1038\/s41698-024-00752-1.","journal-title":"npj Precis. Onc"},{"issue":"12","key":"8301_CR35","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53(12):1712\u201321. https:\/\/doi.org\/10.1038\/s41588-021-00978-w.","journal-title":"Nat Genet"},{"issue":"9","key":"8301_CR36","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra HJ, Bonder MJ, Deelen P, Zeng B, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300\u201310. https:\/\/doi.org\/10.1038\/s41588-021-00913-z.","journal-title":"Nat Genet"},{"key":"8301_CR37","doi-asserted-by":"publisher","unstructured":"Pietzner M, Wheeler E, Carrasco-Zanini J, Cortes A, Koprulu M, W\u00f6rheide MA, et al. Mapping the proteo-genomic convergence of human diseases. Science. 2021;374: eabj 1541.6569). https:\/\/doi.org\/10.1126\/science.abj1541.","DOI":"10.1126\/science.abj1541"},{"key":"8301_CR38","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","volume":"4","author":"S Burgess","year":"2023","unstructured":"Burgess S, Davey Smith G, Davies NM, Dudbridge F, Gill D, Glymour MM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2023;4:186. https:\/\/doi.org\/10.12688\/wellcomeopenres.15555.3.","journal-title":"Wellcome Open Res"},{"issue":"2","key":"8301_CR39","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325. https:\/\/doi.org\/10.1093\/ije\/dyv080.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"8301_CR40","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u201398. https:\/\/doi.org\/10.1038\/s41588-018-0099-7.","journal-title":"Nat Genet"},{"key":"8301_CR41","doi-asserted-by":"publisher","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5):e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383.","DOI":"10.1371\/journal.pgen.1004383"},{"issue":"7873","key":"8301_CR42","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583\u201389. https:\/\/doi.org\/10.1038\/s41586-021-03819-2.","journal-title":"Nature"},{"issue":"8","key":"8301_CR43","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python Bindings. J Chem Inf Model. 2021;61(8):3891\u201398. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203.","journal-title":"J. Chem. Inf. Model"},{"issue":"7800","key":"8301_CR44","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2095-1","volume":"579","author":"GD Poore","year":"2020","unstructured":"Poore GD, Kopylova E, Zhu Q, Carpenter C, Fraraccio S, Wandro S, et al. Retracted article: microbiome analyses of blood and tissues suggest cancerdiagnostic approach. Nature. 2020;579(7800):567\u201374. https:\/\/doi.org\/10.1038\/s41586-020-2095-1.","journal-title":"Nature"},{"issue":"7","key":"8301_CR45","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773\u201382. https:\/\/doi.org\/10.1038\/s41587-019-0114-2.","journal-title":"Nat Biotechnol"},{"issue":"7827","key":"8301_CR46","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-020-2746-2","volume":"586","author":"KA Lawson","year":"2020","unstructured":"Lawson KA, Sousa CM, Zhang X, Kim E, Akthar R, Caumanns JJ, et al. Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. Nature. 2020;586(7827):120\u201326. https:\/\/doi.org\/10.1038\/s41586-020-2746-2.","journal-title":"Nature"},{"issue":"13","key":"8301_CR47","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, 3rd, Mauck WM, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573\u201387.e29. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048.","journal-title":"Cell"},{"issue":"4","key":"8301_CR48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis CS, Murrow LM, Gartner ZJ. DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 2019;8(4):329\u201337.e4. https:\/\/doi.org\/10.1016\/j.cels.2019.03.003.","journal-title":"Cell Syst"},{"issue":"12","key":"8301_CR49","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16(12):1289\u201396. https:\/\/doi.org\/10.1038\/s41592-019-0619-0.","journal-title":"Nat Methods"},{"issue":"2","key":"8301_CR50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20(2):163\u201372. https:\/\/doi.org\/10.1038\/s41590-018-0276-y.","journal-title":"Nat Immunol"},{"issue":"S8","key":"8301_CR51","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/cncr.35176","volume":"130","author":"J Wang","year":"2024","unstructured":"Wang J, Xia YC, Tian BX, Li JT, Li HY, Dong H, et al. Novel quantitative immunohistochemistry method using histone H3, family 3B as the internal reference standard for measuring human epidermal growth factor receptor 2 expression in breast cancer. Cancer. 2024;130(S8):1424\u201334. https:\/\/doi.org\/10.1002\/cncr.35176.","journal-title":"Cancer"},{"key":"8301_CR52","doi-asserted-by":"publisher","unstructured":"Liu T, Huang T, Li J, Li A, Li C, Huang X, et al. Optimization of differentiation and transcriptomic profile of THP-1 cells into macrophage by PMA. PLoS One. 2023;18(7):e0286056. https:\/\/doi.org\/10.1371\/journal.pone.0286056.","DOI":"10.1371\/journal.pone.0286056"},{"key":"8301_CR53","doi-asserted-by":"publisher","unstructured":"Watany M. Study of dickkopf-1 (DKK-1) gene expression in hepatocellular carcinoma patients. JCDR. 2017;11:Oc32\u2013oc34. https:\/\/doi.org\/10.7860\/JCDR\/2017\/23095.9450.","DOI":"10.7860\/JCDR\/2017\/23095.9450"},{"issue":"11","key":"8301_CR54","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1016\/j.celrep.2020.02.062","volume":"30","author":"JH Ko","year":"2020","unstructured":"Ko JH, Kim HJ, Jeong HJ, Lee HJ, Oh JY. Mesenchymal stem and stromal cells harness macrophage-derived amphiregulin to maintain tissue homeostasis. Cell Rep. 2020;30(11):3806\u201320.e6. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.062.","journal-title":"Cell Rep"},{"key":"8301_CR55","doi-asserted-by":"publisher","unstructured":"Zhang F, Jiang Q, Cai J, Meng F, Tang W, Liu Z, et al. Activation of NOD1 on tumor-associated macrophages augments CD8 + T cell\u2013mediated antitumor immunity in hepatocellular carcinoma. Sci Adv. 2024;10(40):eadp 8266. https:\/\/doi.org\/10.1126\/sciadv.adp8266.","DOI":"10.1126\/sciadv.adp8266"},{"issue":"12","key":"8301_CR56","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","volume":"19","author":"LT Roumenina","year":"2019","unstructured":"Roumenina LT, Daugan MV, Petitprez F, Saut\u00e8s-Fridman C, Fridman WH. Context-dependent roles of complement in cancer. Nat Rev Cancer. 2019;19(12):698\u2013715. https:\/\/doi.org\/10.1038\/s41568-019-0210-0.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"8301_CR57","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S, Saeed A, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Sig Transduct Target Ther. 2023;8(1):207. https:\/\/doi.org\/10.1038\/s41392-023-01452-1.","journal-title":"Sig Transduct Target Ther"},{"key":"8301_CR58","doi-asserted-by":"publisher","unstructured":"Yan L, Wang J, Cai X, Liou YC, Shen HM, Hao J, et al. Macrophage plasticity: signaling pathways, tissue repair, and regeneration. MedComm (2020). 2024;5(8):e658. https:\/\/doi.org\/10.1002\/mco2.658.","DOI":"10.1002\/mco2.658"},{"issue":"1","key":"8301_CR59","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41420-023-01356-7","volume":"9","author":"H Zheng","year":"2023","unstructured":"Zheng H, Peng X, Yang S, Li X, Huang M, Wei S, et al. Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy. Cell Death Discov. 2023;9(1):65. https:\/\/doi.org\/10.1038\/s41420-023-01356-7.","journal-title":"Cell Death Discov"},{"issue":"11","key":"8301_CR60","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2174\/1568009619666190718141647","volume":"19","author":"F El-Gebaly","year":"2019","unstructured":"El-Gebaly F, Abou-Saif S, Elkadeem M, Helmy A, Abd-Elsalam S, Yousef M, et al. Study of serum soluble programmed death ligand 1 as a prognostic factor in hepatocellular carcinoma in Egyptian patients. CCDT. 2019;19(11):896\u2013905. https:\/\/doi.org\/10.2174\/1568009619666190718141647.","journal-title":"CCDT"},{"key":"8301_CR61","doi-asserted-by":"publisher","first-page":"1575963","DOI":"10.3389\/fimmu.2025.1575963","volume":"16","author":"Y Feng","year":"2025","unstructured":"Feng Y, Han MZ, Zhou YH, Wang YW, Wang Y, Sun T, et al. The multifaceted role of microbiota in liver cancer: pathogenesis, therapy, prognosis, and immunotherapy. Front Immunol. 2025;16:1575963. https:\/\/doi.org\/10.3389\/fimmu.2025.1575963.","journal-title":"Front. Immunol"},{"key":"8301_CR62","doi-asserted-by":"publisher","unstructured":"Sun L, Ke X, Guan A, Jin B, Qu J, Wang Y, et al. Intratumoural microbiome can predict the prognosis of hepatocellular carcinoma after surgery. Clin Transl Med. 2023;13(7):e 1331. https:\/\/doi.org\/10.1002\/ctm2.1331.","DOI":"10.1002\/ctm2.1331"},{"key":"8301_CR63","doi-asserted-by":"publisher","unstructured":"Jiang F, Dang Y, Zhang Z, Yan Y, Wang Y, Chen Y, et al. Association of intratumoral microbiome diversity with hepatocellular carcinoma prognosis. mSystems. 2025;10(1):e0076524. https:\/\/doi.org\/10.1128\/msystems.00765-24.","DOI":"10.1128\/msystems.00765-24"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08301-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08301-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08301-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:12:07Z","timestamp":1784851927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08301-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8301"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08301-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8712240\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and relevant ethical guidelines. The study protocol was reviewed and approved by the Ethics Committee of Shandong Provincial Hospital Affiliated to Shandong First Medical University (approval no. SWYX:NO.2025\u2013701). Written informed consent was obtained from all participants before surgery and sample collection.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final manuscript and consent to its publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"955"}}